Journey Medical (DERM) Income from Non-Controlling Interests (2021 - 2022)
Journey Medical's (DERM) quarterly Income from Non-Controlling Interests came in at $64000.0 in Q2 2022, down 98.12% YoY from $3.4 million in Q2 2021, and down 38.46% on a QoQ basis from $104000.0 in Q1 2022.
Journey Medical (DERM) Income from Non-Controlling Interests (2021 - 2022) Analysis & Trends
Journey Medical (DERM) has 2 years of Income from Non-Controlling Interests data on file, last reported at $64000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 376,434.15 |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Journey Medical | 207.30 Mn | 181.66 Mn | 12.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | 104,000.00 |
| Jun 30, 2021 | 3.40 Mn |
| Mar 31, 2021 | 96,000.00 |